Alzamend Neuro, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
7.00
|
|
Average Rating
|
5.00
|
|
# Strong Buys
|
1
|
|
# Buys
|
0
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-01-31
|
-0.04
|
0.00
|
0.04
|
100.00%
|
|
2022-10-31
|
-0.04
|
-0.03
|
0.01
|
25.00%
|
|
2022-07-31
|
-0.07
|
-0.03
|
0.04
|
57.14%
|
|
2022-04-30
|
-0.03
|
-0.04
|
-0.01
|
-33.33%
|
|
2022-01-31
|
-0.02
|
-0.03
|
-0.01
|
-50.00%
|
|
2021-10-31
|
-0.02
|
-0.04
|
-0.02
|
-100.00%
|
|
2021-07-31
|
0.00
|
-0.03
|
0.00
|
0.00%
|
|
2021-04-30
|
0.00
|
-0.01
|
-0.01
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-10-31
|
-0.06
|
|
2022-04-30
|
-0.14
|
|
2021-04-30
|
-0.06
|
|
2020-04-30
|
-0.07
|
|
2019-04-30
|
-0.07
|
|
2018-04-30
|
-0.05
|
|
2017-04-30
|
-0.04
|
|
2016-04-30
|
-0.02
|